Get 40% Off
🚀 Our AI Picked 6 Stocks that Jumped +25% in Q1. Which Picks Will Soar in Q2?Unlock full list

Pfizer Inc (PFE)

Lima
Currency in USD
Disclaimer
26.42
-0.78(-2.87%)
Closed

PFE Comments

I appreciate what Pfizer does... But where are the cancer vaccines 9ther companies are developing?
Pfizer is in Europe in the middle of a scandal of proportions together with the president Ursula from. EU because of the strange contracts made during the Covid19 epidemic
Corruption, bribery, blackmail, the regular big pharma MO.
www.investing.com is a good website
Leadership has to be removed to regain the trust of investors.
No, it is corrupt to its core and huge lawsuits will follow.
Pfizer has 88,000 employees, but its stock price is low. Why? Some analysts say Pfizer will hit $45 a share, but I don't think that will happen unless the CEO steps down.
They have a new drug for cancer this will blow up the stock I think in this year to at least 36
Because of pending lawsuits
30+ soon
sad to see a CEO drive a company in the ground and get pad so much money to do it.
will it go up analysis said it will reach 45
6% dividends🤑, why short? Anyone can explain how i can loose money if buy now?
Just the beginning, wait until the compensations start. It will be the end for this sh.....
Cramer says sell
so we must buy
Cramer is mostly wrong
if Cramer says sell, then I'm buying
Short the hell out of this turd buy calls for the temporary upticks take the money out and put it somewhere else !hate this company they are on my attack radar beat em up going up and down . Devalue$$$$
Operater is accumulating, just wait and watch
Yeam, I'm hearing this for the last 2 years...
Most of price movement excessive movement on either side is due to operated. It is good compnay will bounce back. Pfizer is good brand be patient investor will make money
Why does the CEO still run the company? He should step down. My 14 year old son is better than him.
ceo...problem
Pfizer posted a surprising Q4 profit beat driven by their Covid business losing less revenue than expected. In 2021, PFE was up 60% driven by it's Covid vaccines, but shareholders have since lost 13% in 2022 and a further 44% in 2023. Does Pfizer's drug pipeline help shareholders recover from these losses?
Drops on positive earnings surprise... lol
how this CEO still has a job is unbelievable. He has zero credibility or direction on plan to turn this company around.
What is horrible they beat on the top and bottom line
Horrible results
but no reaction so far!
actually they are good if you stop comparing 2023 with oneoff Covid period. Guidance 2024 of single digit rev growth and higher adj EPS show positiveness
🚀🌙
is it time to catch the falling knife or not yet?
Hard to tell, i'm waiting for 20. Liquidity high, fear is low. If inflation ticks higher, the whole market can hit. Buy a portion at last low for a double bottom, cut position of it goes lower, add on the first pullback if it holds.
Buyout.
Hot mess
Market and big techs need to fall for PFE to move up. But they will not fall
are you sure? wait some months
After some months Yes
Pfizer's CEO is the world's worst leader, and he always brings companies down.
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.